Abnormal multiple marker screens are associated with adverse perinatal outcomes in cases of intrauterine growth restriction

American Journal of Obstetrics and Gynecology

Volumn 191, Issue 4, 2004, Pages 1465-1469

  Ilagan, John G ^a   Stamilio, David M ^a   Ural, Serdar H ^a   MacOnes, George A ^a   Odibo, Anthony O ^a,b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b 3400 Spruce St Philadelphia P   (United States)

Author keywords

Abnormal multiple markers; Intrauterine growth restriction; Perinatal outcomes

Indexed keywords

CHORIONIC GONADOTROPIN;

ADULT; BIRTH WEIGHT; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DELIVERY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FETUS; GESTATIONAL AGE; HEMOCONCENTRATION; HUMAN; INTERMETHOD COMPARISON; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; PERINATAL PERIOD; PREGNANCY; PRIORITY JOURNAL; SCREENING TEST; STATISTICAL SIGNIFICANCE;

EID: 7044253664     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.05.065     Document Type: Conference Paper

References (25)

1. P.A. Benn, D. Horne, S. Briganti, J.F. Rodis, and J.M. Clive Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein Obstet Gynecol 87 1996 217 222
2. R.A. Schleifer, L.A. Bradley, D.S. Richards, and N.R. Ponting Pregnancy outcome for women with very low levels of maternal serum unconjugated estriol on second-trimester screening Am J Obstet Gynecol 173 1995 1152 1156
3. A. Milunsky, and L. Nebiolo Maternal serum triple analyte screening and adverse pregnancy outcome Fetal Diagn Ther 11 1996 249 253
4. S. Chandra, H. Scott, L. Dodds, C. Blight, and M. Van Den Hof Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes Am J Obstet Gynecol 189 2003 775 781
5. B.K. Burton Outcome of pregnancy in patients with unexplained elevated or low levels of maternal serum alpha-fetoprotein Obstet Gynecol 72 1988 709 713
6. J.L. Simpson, G.E. Palomaki, B. Mercer, J.E. Haddow, R. Andersen, and B. Sibai Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements Am J Obstet Gynecol 173 1995 1742 1748
7. D.K. Waller, L.S. Lustig, G.C. Cunningham, M.S. Golbus, and E.B. Hook Second trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death N Engl J Med 325 1991 6 10
8. L.S. Onderoglu, and A. Kabukcu Elevated second trimester human chorionic gonadotropin level associated with adverse pregnancy outcome Int J Gynecol Obstet 56 1997 245 249
9. R. Gonen, R. Perez, M. David, H. Dar, R. Merksamer, and M. Sharf The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications Obstet Gynecol 80 1992 83 86
10. A.S. Berkeley, M.A. Killackey, and L.L. Cederqvist Elevated maternal serum alpha-fetoprotein levels associated with breakdown in fetal-maternal- placental barrier Am J Obstet Gynecol 146 1983 859 861
11. J.L. Bartha, R. Romero-Carmona, M. Escobar-Llompart, O. Paloma-Castro, and R. Comino-Delgado Human chorionic gonadotropin and vascular endothelial growth factor in normal and complicated pregnancies Obstet Gynecol 102 2003 995 999
12. T.D. Kowalczyk, M.L. Cabaniss, and L. Cusmano Association of low unconjugated estriol in the second trimester and adverse pregnancy outcome Obstet Gynecol 91 1998 396 400
13. L.A. Bradley, J.A. Canick, G.E. Palomaki, and J.E. Haddow Undetectable maternal serum unconjugated estriol levels in the second trimester: risk of perinatal complications associated with placental sulfatase deficiency Am J Obstet Gynecol 176 1997 531 535
14. E. Schoen, C. Norem, J. O'Keefe, R. Krieger, D. Walton, and T.T. To Maternal serum unconjugated estriol as a predictor for Smith-Lemli-Opitz syndrome and other fetal conditions Obstet Gynecol 102 2003 167 172
15. American College of Obstetricians and Gynecologists. Intrauterine growth restriction 2000 The College Washington (DC)
16. J.M. Piper, E.M.J. Xenakis, M. McFarland, B.D. Elliot, M.D. Berkus, and O. Langer Do growth-retarded premature infants have different rates of perinatal morbidity and mortality than appropriate grown premature infants? Obstet Gynecol 87 1996 169 174
17. J.H. Kok, A.L. den Ouden, S.P. Verloove-Vanhorick, and R. Brand Outcome of very preterm small for gestational age infants: the first nine years of life BJOG 105 1998 162 168
18. W.E. Brenner, D.A. Edelman, and C.H. Hendricks A standard of fetal growth for the United States of America Am J Obstet Gynecol 126 1976 555 564
19. G.R. Alexander, J.H. Himes, R.B. Kaufman, J. Mor, and M. Kogan A United States national reference for fetal growth Obstet Gynecol 87 1996 163 168
20. R.E. Lieppman, M.A. Williams, E.Y. Cheng, R. Resta, R. Zingheim, and D.E. Hickok An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome Am J Obstet Gynecol 168 1993 1852 1856
21. C.D. Hsu, D.W. Chan, B. Iriye, T.R. Johnson, S.F. Hong, and J.T. Repke Elevated serum human chorionic gonadotropin as evidence of secretory response in severe preeclampsia Am J Obstet Gynecol 170 1994 1135 1138
22. P. Saenger, Z. Klonari, S.M. Black, N. Compagnone, S.H. Mellon, and A. Fleischer Prenatal diagnosis of congenital lipoid adrenal hyperplasia J Clin Endocrinol Metab 80 1995 200 205
23. P.A. Benn, A. Craffey, D. Horne, L. Ramsdell, and J.F. Rodis Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome J Matern Fetal Med 9 2000 165 169
24. M. Van Rijn, Y.T. Van der Schouw, A.M. Hagenaars, G.H.A. Visser, and G.C.M.L. Christiaens Adverse obstetric outcome in low- and high-risk pregnancies: predictive value of maternal serum screening Obstet Gynecol 94 1999 329 334
25. K.D. Wenstrom, J. Owen, R.O. Davis, and C.G. Brumfield Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein Obstet Gynecol 87 1996 213 216